Pediatric Prurigo Nodularis (Ages 0-17) - CPL | US
Offer Details: | |
|---|---|
| Offer Name: | Pediatric Prurigo Nodularis (Ages 0-17) - CPL | US |
| Payout: | $77.00 / CPA |
| Preview: | Preview Landing Page |
| Categories: | Clinical Trials |
| Network: | DYNU IN MEDIA |
| Last Updated: | Sep 12, 2025 |
| Countries: | US |
GEO: US (zip code)
Description: Study should be recruiting for until 2027
Ages: 0-17
Gender: Any
Study Description:
The purpose of this clinical study is to learn more about the investigational injectable medication dupilumab for treating Prurigo Nodularis in children and adolescents. If enrolled, your child may receive the investigational medication as an injection 6 to 12 times, depending on the weight of the child, over the course of approximately 6 months. Study procedures will include blood draws, physical examinations, and electronic diary entries. Total participation will last approximately 10 months and include up to 6 office visits. Participants will receive trial-related procedures and study medication at no cost.
Qualifications:
- Itch must be at least a 7 out of 1-10 scale
- Child must have at least 6+ bumps
- At least two areas of your child's body must be affected by itchy bumps
- Cannot have ever used the self-injectable medication Dupixent (Dupilumab)
- Child cannot be taking: Gabarone (Gabapentin), Lyrica (Pregabalin), or Thalomid (Thalidomide)
Mailer Access Key
https://www.affiliateaccesskey.com/m-dzkm-u57-1731678d72826ec76f7442305fba216d
Optout Link
https://www.twonailhall.com/o-dzkm-u57-160a4733f374bcf8a7d89f0c714ff769
NEED PROOF
Description: Study should be recruiting for until 2027
Ages: 0-17
Gender: Any
Study Description:
The purpose of this clinical study is to learn more about the investigational injectable medication dupilumab for treating Prurigo Nodularis in children and adolescents. If enrolled, your child may receive the investigational medication as an injection 6 to 12 times, depending on the weight of the child, over the course of approximately 6 months. Study procedures will include blood draws, physical examinations, and electronic diary entries. Total participation will last approximately 10 months and include up to 6 office visits. Participants will receive trial-related procedures and study medication at no cost.
Qualifications:
- Itch must be at least a 7 out of 1-10 scale
- Child must have at least 6+ bumps
- At least two areas of your child's body must be affected by itchy bumps
- Cannot have ever used the self-injectable medication Dupixent (Dupilumab)
- Child cannot be taking: Gabarone (Gabapentin), Lyrica (Pregabalin), or Thalomid (Thalidomide)
Mailer Access Key
https://www.affiliateaccesskey.com/m-dzkm-u57-1731678d72826ec76f7442305fba216d
Optout Link
https://www.twonailhall.com/o-dzkm-u57-160a4733f374bcf8a7d89f0c714ff769
NEED PROOF
DYNU IN MEDIA
DYNU IN MEDIA is a super match CPA/CPL network for earning money online that provides you with all techniques allowing you to monetize your traffic in all channels. We guarantee outstanding support to our publishers. Our devoted team with experience in the affiliate marketing industry will give you full-assist, direct offers in a wide-ranging variety of verticals and top GEOs, and a flexible payment schedule of NET15 & NET30. Hitting more than 20,000 leads generated daily for over 200 influential clients, along with an increasing number of HQ publishers to 300 and more, DYNU IN MEDIA is taking high pride in our professionalism and high integrity.
